Literature DB >> 3719284

Oculopalatal myoclonus.

T Nakada, I L Kwee.   

Abstract

Five cases of oculopalatal myoclonus (OPM) were studied. Three exhibited the lateral form, characterized by jerky nystagmoid eye movements with simultaneous oblique and rotatory components, associated with lateralized palatal myoclonus, and 2 the midline form, characterized by vertical to-and-fro pendular eye movements with symmetric bilateral palatal myoclonus. Structural studies using computed tomography (CT) and proton nuclear magnetic resonance (NMR) imaging indicated that the integrity of the flocculus was preserved in all 5 cases. We postulate that the generation of ocular oscillations in OPM involves vestibulo-ocular reflex (VOR) adaptation mediated by the flocculus. The lateral form represents unilateral disease, whereas the midline form represents bilateral disease.

Entities:  

Mesh:

Year:  1986        PMID: 3719284     DOI: 10.1093/brain/109.3.431

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  4 in total

1.  Acquired pendular nystagmus in multiple sclerosis: clinical observations and the role of optic neuropathy.

Authors:  J J Barton; T A Cox
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-03       Impact factor: 10.154

Review 2.  The diagnostic value of saccades in movement disorder patients: a practical guide and review.

Authors:  Pichet Termsarasab; Thananan Thammongkolchai; Janet C Rucker; Steven J Frucht
Journal:  J Clin Mov Disord       Date:  2015-10-15

Review 3.  Hypertrophic Olivary Degeneration and Palatal or Oculopalatal Tremor.

Authors:  Caroline Tilikete; Virginie Desestret
Journal:  Front Neurol       Date:  2017-06-29       Impact factor: 4.003

4.  Oculopalatal tremor explained by a model of inferior olivary hypertrophy and cerebellar plasticity.

Authors:  Aasef G Shaikh; Simon Hong; Ke Liao; Jing Tian; David Solomon; David S Zee; R John Leigh; Lance M Optican
Journal:  Brain       Date:  2010-01-15       Impact factor: 13.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.